NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)

RecruitingPhase 1

Sponsor: Merck Sharp & Dohme LLC

Conditions: Healthy

Interventions: MK-0616A, Enlicitide, Rosuvastatin

Countries: United States

This goal of this trial is to learn about two medicines, enlicitide and rosuvastatin, in healthy people. Researchers will compare the amounts of enlicitide and rosuvastatin in a person's body over time, when they are given as separate medicines and when they are combined into one tablet.

Eligibility overview

Sex: ALL

Age: 18 Years to 55 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

The main inclusion criteria include but are not limited to the following:

* Is medically healthy with no clinically significant medical history
* Is a non-smoker who has not used nicotine- and tobacco-containing products for at least 3 months prior to study entry

Exclusion Criteria:

* Is unable to refrain from or anticipates the use of any drugs, including prescription and non-prescription medications, herbal remedies, or vitamin supplements beginning 14 days prior to study entry
* Is a female participant of childbearing potential

Locations (1)

Tempe, Arizona, United States